Baylor College of Medicine is recruiting men and women between the ages of 18 and 65 who have been diagnosed with obsessive compulsive disorder and are not satisfied with their current serotonin-blocking, or SSRI, medication.
A team of physician-scientists at Baylor College of Medicine and Texas Children’s Hospital are now using a new treatment option for pediatric patients with liver tumors, called Transarterial Radioembolization (TARE).
The National Cancer Institute has awarded $6.3 million dollars Baylor researchers to create new tools to help researchers to better understand the biological causes behind racial and ethnic health disparities in prostate and breast cancers.
Dr. Hsiao-Tuan Chao, instructor of pediatrics at Baylor College of Medicine, has been awarded the NIH's High-Risk, High-Reward grant, which recognizes highly innovative research to address major challenges in biomedical research.
The All of Us Research Program, part of the National Institutes of Health, has named a consortia led by Baylor's Human Genome Sequencing Center as one of three centers responsible for generating clinical grade genomic data for the program.